These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 11526479)
1. IGF-II induces rapid beta-catenin relocation to the nucleus during epithelium to mesenchyme transition. Morali OG; Delmas V; Moore R; Jeanney C; Thiery JP; Larue L Oncogene; 2001 Aug; 20(36):4942-50. PubMed ID: 11526479 [TBL] [Abstract][Full Text] [Related]
2. beta-Catenin and TGFbeta signalling cooperate to maintain a mesenchymal phenotype after FosER-induced epithelial to mesenchymal transition. Eger A; Stockinger A; Park J; Langkopf E; Mikula M; Gotzmann J; Mikulits W; Beug H; Foisner R Oncogene; 2004 Apr; 23(15):2672-2680. PubMed ID: 14755243 [TBL] [Abstract][Full Text] [Related]
3. Decreased E-cadherin augments beta-catenin nuclear localization: studies in breast cancer cell lines. Yang SZ; Kohno N; Yokoyama A; Kondo K; Hamada H; Hiwada K Int J Oncol; 2001 Mar; 18(3):541-8. PubMed ID: 11179484 [TBL] [Abstract][Full Text] [Related]
4. Significance of E-cadherin/beta-catenin complex and cyclin D1 in breast cancer. Lim SC; Lee MS Oncol Rep; 2002; 9(5):915-28. PubMed ID: 12168049 [TBL] [Abstract][Full Text] [Related]
5. Tyrosine phosphorylation translocates beta-catenin from cell-->cell interface to the cytoplasm, but does not significantly enhance the LEF-1-dependent transactivating function. Kim K; Lee KY Cell Biol Int; 2001; 25(5):421-7. PubMed ID: 11401329 [TBL] [Abstract][Full Text] [Related]
7. Tissue-specific expression of beta-catenin in normal mesenchyme and uveal melanomas and its effect on invasiveness. Kim K; Daniels KJ; Hay ED Exp Cell Res; 1998 Nov; 245(1):79-90. PubMed ID: 9828103 [TBL] [Abstract][Full Text] [Related]
8. Beta-catenin interacts with low-molecular-weight protein tyrosine phosphatase leading to cadherin-mediated cell-cell adhesion increase. Taddei ML; Chiarugi P; Cirri P; Buricchi F; Fiaschi T; Giannoni E; Talini D; Cozzi G; Formigli L; Raugei G; Ramponi G Cancer Res; 2002 Nov; 62(22):6489-99. PubMed ID: 12438242 [TBL] [Abstract][Full Text] [Related]
9. Cellular localization and signaling activity of beta-catenin in migrating neural crest cells. de Melker AA; Desban N; Duband JL Dev Dyn; 2004 Aug; 230(4):708-26. PubMed ID: 15254905 [TBL] [Abstract][Full Text] [Related]
10. Restoration of full-length adenomatous polyposis coli (APC) protein in a colon cancer cell line enhances cell adhesion. Faux MC; Ross JL; Meeker C; Johns T; Ji H; Simpson RJ; Layton MJ; Burgess AW J Cell Sci; 2004 Jan; 117(Pt 3):427-39. PubMed ID: 14679305 [TBL] [Abstract][Full Text] [Related]
11. R-cadherin:beta-catenin complex and its association with vascular smooth muscle cell proliferation. Slater SC; Koutsouki E; Jackson CL; Bush RC; Angelini GD; Newby AC; George SJ Arterioscler Thromb Vasc Biol; 2004 Jul; 24(7):1204-10. PubMed ID: 15117735 [TBL] [Abstract][Full Text] [Related]
12. Tumor progression induced by the loss of E-cadherin independent of beta-catenin/Tcf-mediated Wnt signaling. Herzig M; Savarese F; Novatchkova M; Semb H; Christofori G Oncogene; 2007 Apr; 26(16):2290-8. PubMed ID: 17043652 [TBL] [Abstract][Full Text] [Related]
13. E-cadherin modulates Wnt-dependent transcription in colorectal cancer cells but does not alter Wnt-independent gene expression in fibroblasts. Kuphal F; Behrens J Exp Cell Res; 2006 Feb; 312(4):457-67. PubMed ID: 16368435 [TBL] [Abstract][Full Text] [Related]
14. Mastermind-like 1 Is a specific coactivator of beta-catenin transcription activation and is essential for colon carcinoma cell survival. Alves-Guerra MC; Ronchini C; Capobianco AJ Cancer Res; 2007 Sep; 67(18):8690-8. PubMed ID: 17875709 [TBL] [Abstract][Full Text] [Related]
15. Exchange of catenins in cadherin-catenin complex. Klingelhöfer J; Troyanovsky RB; Laur OY; Troyanovsky S Oncogene; 2003 Feb; 22(8):1181-8. PubMed ID: 12606944 [TBL] [Abstract][Full Text] [Related]
16. Beta-catenin abnormalities and associated insulin-like growth factor overexpression are important in phyllodes tumours and fibroadenomas of the breast. Sawyer EJ; Hanby AM; Poulsom R; Jeffery R; Gillett CE; Ellis IO; Ellis P; Tomlinson IP J Pathol; 2003 Aug; 200(5):627-32. PubMed ID: 12898599 [TBL] [Abstract][Full Text] [Related]
17. [Correlation among expression of E-cadherin, beta-catenin, and cyclin D1 in breast cancers]. Yang JF; Chen SL; Liu ZH; Zhang Y Ai Zheng; 2004 Jul; 23(7):799-802. PubMed ID: 15248915 [TBL] [Abstract][Full Text] [Related]
18. Abnormal beta-catenin expression in oral cancer with no gene mutation: correlation with expression of cyclin D1 and epidermal growth factor receptor, Ki-67 labeling index, and clinicopathological features. Odajima T; Sasaki Y; Tanaka N; Kato-Mori Y; Asanuma H; Ikeda T; Satoh M; Hiratsuka H; Tokino T; Sawada N Hum Pathol; 2005 Mar; 36(3):234-41. PubMed ID: 15791567 [TBL] [Abstract][Full Text] [Related]
20. Functional localization and competition between the androgen receptor and T-cell factor for nuclear beta-catenin: a means for inhibition of the Tcf signaling axis. Mulholland DJ; Read JT; Rennie PS; Cox ME; Nelson CC Oncogene; 2003 Aug; 22(36):5602-13. PubMed ID: 12944908 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]